CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

BCR::ABL1 fusion (Ph+)

Gene: BCR::ABL1 · Type: fusion

Indications: Chronic myeloid leukemia, Acute lymphoblastic leukemia

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
ImatinibChronic myeloid leukemia, Acute lymphoblastic leukemiaINDICATED
FDA Label
Label
DasatinibChronic myeloid leukemia, Acute lymphoblastic leukemiaINDICATED
FDA Label
Label
NilotinibChronic myeloid leukemia, Acute lymphoblastic leukemiaINDICATED
FDA Label
Label
BosutinibChronic myeloid leukemia, Acute lymphoblastic leukemiaINDICATED
FDA Label
Label
PonatinibChronic myeloid leukemia, Acute lymphoblastic leukemiaINDICATED
FDA Label
Label
AsciminibChronic myeloid leukemia, Acute lymphoblastic leukemiaINDICATED
FDA Label
Label